title: Evaluation of the objective posturo-locomotor-manual method in patients with parkinsonian syndromes.
abstract: Objective methods for quantifying patients' movement capacity would be useful in evaluating progression and interventions in neurodegenerative diseases. The Posturo-Locomotor-Manual (PLM) test is a standardized automated movement test developed to measure hypokinetic movements in patients with Parkinsonism. Our hypotheses were that the PLM movement time (MT) correlates with the Unified Parkinson's disease rating scale (UPDRS III) motor section, and that the components of the PLM test correlate with the corresponding constructed domains of UPDRS III. We also evaluated the coherence between the results of the two assessment methods after a test dose of levodopa (l-DOPA). We assessed motor function using the PLM method and UPDRS III in parallel, in the absence of medication and after administration of 200 mg l-DOPA, in 73 patients with moderate to advanced Parkinsonism: 47 with Parkinson's disease (PD), 17 with multiple system atrophy (MSA), and 9 with progressive supranuclear palsy (PSP). There was a fair correlation between the two assessment tools in the PD patients but not in the MSA or PSP patients. In the full dataset, there was a fair to good correlation between UPDRS III and the PLM MT. At group level, the UPDRS III l-DOPA test differentiated PD from MSA/PSP, whereas the PLM l-DOPA test differentiated between all three diagnoses.
authors.affiliation: Department of Clinical Neuroscience and Rehabilitation, Institute of Neuroscience and Physiology, University of Gothenburg , Gothenburg , Sweden.
authors.forename: Theresa
authors.initials: T
authors.lastname: Zackrisson
authors.forename: Filip
authors.initials: F
authors.lastname: Bergquist
authors.forename: Björn
authors.initials: B
authors.lastname: Holmberg
authors.forename: Bo
authors.initials: B
authors.lastname: Johnels
authors.forename: Thorleif
authors.initials: T
authors.lastname: Thorlin
keywords: PLM test; Parkinsonism; Parkinson’s disease; UPDRS III; l-DOPA test; movement disorders; optoelectronic movement analysis